跳至主要内容
临床试验/NCT06938698
NCT06938698已完成不适用

PROMs From GEstIC Heart Failure Patients - PROFIC-HF Study

Centro Hospitalar do Porto1 个研究点 分布在 1 个国家目标入组 155 人开始时间: 2022年12月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
155
试验地点
1
主要终点
Health-related quality of life as measured by KCCQ-12 versus MLHFQ

研究概览

简要总结

Heart failure (HF) is a chronic condition with substantial morbidity, and understanding its effects on patients' quality of life is essential.

Patient-reported outcomes (PROs) are any result of a disease or treatment that comes directly from the patient, without any interpretation from clinicians, using standardized scientifically-validated medical questionnaires, PROMs. Patient-reported outcome measures (PROMs) are the tools used to capture PRO information usually in the form of questionnaires.

The PROMs from GEstIC Heart Failure Patients (PROFIC-HF) study aims to assess the feasibility of digitally recording Patient-Reported Outcome Measures (PROMs) at home in real-world patients enrolled in a multidisciplinary heart failure clinic. Two HF-specific PROMs - Kansas City Questionnaire (KCCQ-12) and the Minnesota Living with Heart Failure Questionnaire (MLHFQ) - and a 2 PROMs for anxiety and depression assessment - Patient Health Questionnaire -2 (PHQ-2) and The Hospital Anxiety and Depression Scale (HADS) will be collected remotely using a digital platform that can be accessed online using a smartphone or a computer.

This study will also evaluate the correlation between quality of life changes (measured by Kansas City Cardiomyopathy Questionnaire (KCCQ-12) versus Minnesota Living with Heart Failure Questionnaire) and changes in clinical reported outcomes: assess the quality of life of real world HFpatients followed in a multidisciplinary heart failure clinic and quantify the impact of hospitalization events on patients' quality of life.

详细描述

PROFIC-HF will randomize 75 participants to complete the Kansas City Cardiomyopathy Questionnaire (KCCQ-12) and 75 to complete the Minnesota Living with Heart Failure Questionnaire (MLHFQ).

The trial will pilot the use of the digital PROMs system, collected from the consultation waiting room and/or with the patient at home.

PROMs will be based on the HF Standard Set created by the International Consortium of Health Outcomes Measurements (ICHOM), adapted to the patient follow-up program already in use by GEstIC.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written Informed Consent (IC) signed before any study- specific procedure,
  • Adult patients diagnosed with HF, undergoing treatment at GEstIC,
  • Ability and willingness to understand the proposed questionnaires, per physician judgment and
  • Ability and willingness to access the platform for completing the data by themselves or with the help of a caregiver (proxy)

排除标准

  • Inability to give the answers to the questions in the questionnaires,
  • Moderate or severe cognitive impairment that precludes the understanding of the questions, per physician judgment,
  • Malignancy or other non-cardiac condition limiting life-expectancy to < 12 months, per physician judgment or
  • Any other condition or therapy that would make the subject unsuitable to this study and would not allow participation for the full planned study period, in the judgment of the investigator.

结局指标

主要结局

Health-related quality of life as measured by KCCQ-12 versus MLHFQ

时间窗: Measurement at 0, 1 and 6 months after informed consent.

Kansas City Cardiomyopathy Questionnaire (KCCQ-12) and Minnesota living with Heart Failure (MLHFQ) are a quality of life (QoL) questionnaires specific for heart failure. Patients will be randomized to answer to only one of the questionnaires. KCCQ consists of 12 questions specific to HF and appraises QoL over the last two weeks; scores range from 0 to 100, where higher score means better QoL. The MLHFQ consists of 21 questions and appraises QoL over the previous month. Questions are answered using a Likert scale ranging from 0-5; score range is 0-105, with higher score representing a poorer QoL.

次要结局

  • Correlation between quality of life changes, measured by Kansas City Cardiomyopathy Questionnaire (KCCQ-12) versus Minnesota Living with Heart Failure Questionnaire (MLHFQ), and changes in clinical reported outcomes.(Measurement at 0, 1 and 6 months after informed consent.)
  • Assessment the effect of HF hospitalizations in the quality of life of real world HF patients.(Measurement at 0, 1 and 6 months from discharge.)
  • Assessment of anxiety and depression by Hospital Anxiety and Depression Scale (HADS)(Measurement at 0, 1 and 6 months after informed consent.)

研究者

发起方
Centro Hospitalar do Porto
申办方类型
Other
责任方
Principal Investigator
主要研究者

Irene Marques

Internal Medicine Senior Consultant

Centro Hospitalar do Porto

研究点 (1)

Loading locations...

相似试验